Moonen CTW - Search Results

1

Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors.

Ojha T, Pathak V, Shi Y, Hennink WE, Moonen CTW, Storm G, Kiessling F, Lammers T. Ojha T, et al. Among authors: moonen ctw. Adv Drug Deliv Rev. 2017 Sep 15;119:44-60. doi: 10.1016/j.addr.2017.07.007. Epub 2017 Jul 8. Adv Drug Deliv Rev. 2017. PMID: 28697952 Free PMC article. Review.

2

Sonopermeation to improve drug delivery to tumors: from fundamental understanding to clinical translation.

Snipstad S, Sulheim E, de Lange Davies C, Moonen C, Storm G, Kiessling F, Schmid R, Lammers T. Snipstad S, et al. Expert Opin Drug Deliv. 2018 Dec;15(12):1249-1261. doi: 10.1080/17425247.2018.1547279. Epub 2018 Nov 19. Expert Opin Drug Deliv. 2018. PMID: 30415585 Review.

3

Increase of intracellular cisplatin levels and radiosensitization by ultrasound in combination with microbubbles.

Lammertink BHA, Bos C, van der Wurff-Jacobs KM, Storm G, Moonen CT, Deckers R. Lammertink BHA, et al. J Control Release. 2016 Sep 28;238:157-165. doi: 10.1016/j.jconrel.2016.07.049. Epub 2016 Jul 29. J Control Release. 2016. PMID: 27476609

4

Advanced Ultrasound Technologies for Diagnosis and Therapy.

Rix A, Lederle W, Theek B, Lammers T, Moonen C, Schmitz G, Kiessling F. Rix A, et al. J Nucl Med. 2018 May;59(5):740-746. doi: 10.2967/jnumed.117.200030. Epub 2018 Mar 1. J Nucl Med. 2018. PMID: 29496981 Free article.

5

Hyperthermia-triggered release of hypoxic cell radiosensitizers from temperature-sensitive liposomes improves radiotherapy efficacy in vitro.

Sadeghi N, Kok RJ, Bos C, Zandvliet M, Geerts WJC, Storm G, Moonen CTW, Lammers T, Deckers R. Sadeghi N, et al. Among authors: moonen ctw. Nanotechnology. 2019 Jun 28;30(26):264001. doi: 10.1088/1361-6528/ab0ce6. Epub 2019 Mar 5. Nanotechnology. 2019. PMID: 30836341

6

A Doxorubicin-Glucuronide Prodrug Released from Nanogels Activated by High-Intensity Focused Ultrasound Liberated β-Glucuronidase.

Besse HC, Chen Y, Scheeren HW, Metselaar JM, Lammers T, Moonen CTW, Hennink WE, Deckers R. Besse HC, et al. Among authors: moonen ctw. Pharmaceutics. 2020 Jun 10;12(6):536. doi: 10.3390/pharmaceutics12060536. Pharmaceutics. 2020. PMID: 32532061 Free PMC article.

7

Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives.

Roemhild K, Besse HC, Wang B, Peña Q, Sun Q, Omata D, Ozbakir B, Bos C, Scheeren HW, Storm G, Metselaar JM, Yu H, Knüchel-Clarke R, Kiessling F, Moonen CTW, Deckers R, Shi Y, Lammers T. Roemhild K, et al. Among authors: moonen ctw. Theranostics. 2022 Jun 6;12(10):4791-4801. doi: 10.7150/thno.69168. eCollection 2022. Theranostics. 2022. PMID: 35832083 Free PMC article.

8

Duration of ultrasound-mediated enhanced plasma membrane permeability.

Lammertink B, Deckers R, Storm G, Moonen C, Bos C. Lammertink B, et al. Int J Pharm. 2015 Mar 30;482(1-2):92-8. doi: 10.1016/j.ijpharm.2014.12.013. Epub 2014 Dec 11. Int J Pharm. 2015. PMID: 25497443

9

Development of a tumor tissue-mimicking model with endothelial cell layer and collagen gel for evaluating drug penetration.

Sasaki N, Bos C, Escoffre JM, Storm G, Moonen C. Sasaki N, et al. Int J Pharm. 2015 Mar 30;482(1-2):118-22. doi: 10.1016/j.ijpharm.2015.01.039. Epub 2015 Jan 21. Int J Pharm. 2015. PMID: 25617677

10

Sonochemotherapy: from bench to bedside.

Lammertink BH, Bos C, Deckers R, Storm G, Moonen CT, Escoffre JM. Lammertink BH, et al. Front Pharmacol. 2015 Jul 10;6:138. doi: 10.3389/fphar.2015.00138. eCollection 2015. Front Pharmacol. 2015. PMID: 26217226 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

278 results

Search Page